Adaptive vs. Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

About this trial

The objective of the CLOSE-PD study is to compare the efficacy of adaptive deep brain stimulation (aDBS) with continue deep brain stimulation (cDBS) in patients with Parkinson's disease. The main question it aims to answer is:

\- whether the change in daily mean ON time without troublesome dyskinesia in aDBS is greater than cDBS over a six-month follow-up period?

Researchers will compare aDBS to regular continue deep brain stimulation (cDBS).

Participants will:

* be set up to cDBS during the first programming visit (visit 2); * be randomized 1:1 to aDBS or cDBS two weeks after visit 2; * follow-up will be at three and six months after visit 2; * complete PD Home diary at baseline, two weeks, three months and at six months after visit 2.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Diagnosis of idiopathic PD based on the UK Brain Bank criteria (Hughes et al. 1992);

Age older than 18 years;

Previous implantation of Medtronic PerceptTM PC/RC DBS electrodes bilateral targeting the STN;

Optimal contact point compatible with aDBS in at least one STN;

Disqualifiers

Legally incompetent adults;

Patients with ongoing participation in other clinical trials involving neurological interventions;

Inability to recognize the difference between the motor ON or OFF state;

Mild cognitive impairment or dementia;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Adaptive DBS

    Other intervention

    The Medtronic Percept device will be activated with the aDBS functionality. Participant will receive adaptive DBS.

  • Continue DBS

    Other intervention

    The Medtronic Percept device will be equipped with aDBS functionality (to maintain the blinding of the allocation), but this functionality will remain inactive. Participant will receive continue DBS.

Treatment groups

130 Participants
are divided into 2 treatment groups
Group A: aDBS groupExperimental treatment 1 intervention
Group B: cDBS groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Home PD diary

The primary outcome is the comparison between the aDBS group and the cDBS group of the change from baseline to six months in mean daily ON time without troublesome dyskinesia. Daily ON time without troublesome dyskinesia is measured with the PD home diary. The PD home diary is a self-reported tool for tracking motor symptoms in Parkinson's patients every 30 minutes for three days within a one-week window

Time frame
change from baseline to six months of DBS

Secondary outcomes

1

PD Home diary

ON time without troublesome dyskinesia

Time frame
during six months of follow-up
2

PD Home diary

ON time with troublesome dyskinesia

Time frame
during six months of follow-up
3

PD Home diary

ON time without dyskinesia

Time frame
during six months of follow-up
4

PD Home diary

OFF time

Time frame
during six months of follow-up

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Lead sponsor

HagaZiekenhuis

Collaborator

Maastricht University Medical Center

Collaborator

Universitair Ziekenhuis Leuven

Collaborator